Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.50 |
| ▸ | CRYAB | P02511 | 5/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | USP2 | O75604 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CRYAA | P02489 | 1/20 | 0.46 |
| ▸ | FNTA | P49354 | 2/20 | 0.45 |
| ▸ | FNTB | P49356 | 2/20 | 0.45 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.43 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Obtusifoliol SCHEMBL13324285 | 1.00 | PTPN1 (0.50) | PTPN1CRYABMAPTUSP2ALDH1A1 | |
| Obtusifoliol SCHEMBL19270848 | 1.00 | PTPN1 (0.50) | PTPN1CRYABMAPTUSP2ALDH1A1 | |
| Obtusifoliol SCHEMBL8995509 | 1.00 | PTPN1 (0.50) | PTPN1CRYABMAPTUSP2ALDH1A1 | |
| Obtusifoliol SCHEMBL2511101 | 1.00 | PTPN1 (0.50) | PTPN1CRYABMAPTUSP2ALDH1A1 | |
| Obtusifoliol SCHEMBL5489603 | 1.00 | PTPN1 (0.50) | PTPN1CRYABMAPTUSP2ALDH1A1 | |
| SCHEMBL2508949 | 0.86 | CRYAB (0.47) | PTPN1CRYABMAPTUSP2ALDH1A1 | |
| SCHEMBL29940774 | 0.83 | MAPT (0.68) | CRYABMAPTUSP2ALDH1A1CYP3A4 | |
| SCHEMBL26641924 | 0.83 | MAPT (0.68) | CRYABMAPTUSP2ALDH1A1CYP3A4 | |
| SCHEMBL26641929 | 0.83 | MAPT (0.68) | CRYABMAPTUSP2ALDH1A1CYP3A4 | |
| SCHEMBL25765071 | 0.82 | PTPN1 (0.37) | PTPN1CRYABMAPTUSP2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 215 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260020564-A1 | FUNGAL DISEASES REDUCTION AND YIELD IMPROVEMENT METHODS AND COMPOSITION THEREOF | ELICIT PLANT (FR) | 2026-01-22 | — | — | US | claimed |
| US-20260020568-A1 | FUNGAL DISEASES REDUCTION AND YIELD IMPROVEMENT METHODS AND COMPOSITION THEREOF | ELICIT PLANT (FR) | 2026-01-22 | — | — | US | claimed |
| CN-114306547-A | Traditional Chinese medicine formula for regulating and controlling intestinal function of pregnant women | 华子昂 | 2022-04-12 | — | — | CN | claimed |
| CN-102885937-A | Preparation method and application of morelberry effective fractions | JINAN XINGYI MED TECH CO LTD | 2013-01-23 | — | — | CN | claimed |
| US-7906710-B2 | Transgenic plants containing altered levels of steroid compounds | MONSANTO COMPANY (US) | 2011-03-15 | — | — | US | claimed |
| US-20100037354-A1 | TRANSGENIC PLANTS CONTAINING ALTERED LEVELS OF STEROID COMPOUNDS | KARUNANANDAA BALASULOJINI | 2010-02-11 | — | — | US | claimed |
| EP-1301460-B9 | METHOD FOR PREPARING A FATTY SUBSTANCE ESTER AND USE THEREOF IN PHARMACEUTICS, COSMETICS OR FOOD INDUSTRY | EXPANSCIENCE LAB (FR) | 2009-03-11 | — | — | EP | claimed |
| EP-1301460-B1 | METHOD FOR PREPARING A FATTY SUBSTANCE ESTER AND USE THEREOF IN PHARMACEUTICS, COSMETICS OR FOOD INDUSTRY | EXPANSCIENCE LAB (FR) | 2008-08-06 | — | — | EP | claimed |
| CN-1227212-C | Method for preparing aliphatic ester and application of aliphatic ester in pharmaceutical, cosmetic or food industry | LAB PHARMASCIENCE (FR) | 2005-11-16 | — | — | CN | claimed |
| US-20050086713-A1 | Transgenic plants containing altered levels of steroid compounds | KARUNANANDAA BALASULOJINI (US) | 2005-04-21 | — | — | US | claimed |
| US-20040259732-A1 | Treatment of plants and plant propagation materials with an antioxidant to improve plant health and/or yield | MONSANTO TECHNOLOGY, L.L.C. | 2004-12-23 | — | — | US | claimed |
| US-6828451-B2 | Fatty substance is esterified with alcohol selected from sterols, stanols, 4-methylsterols and their hydrogenated homologs, triterpene alcohols, and mixtures, in presence of solid lanthanide metal oxide catalyst | LABORATOIRES EXPANSCIENCE (FR) | 2004-12-07 | — | — | US | claimed |
| WO-2004095926-A2 | TREATMENT OF PLANTS AND PLANT PROPAGATION MATERIALS WITH AN ANTIOXIDANT TO IMPROVE PLANT HEALTH AND/OR YIELD | MONSANTO TECHNOLOGY, LLC (US) | 2004-11-11 | — | — | WO | claimed |
| EP-1381267-A2 | TRANSGENIC PLANTS CONTAINING ALTERED LEVELS OF STEROID COMPOUNDS | Monsanto Technology LLC (US) | 2004-01-21 | — | — | EP | claimed |
| US-20030217384-A1 | Obtusifoliol 14a-demethylase | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-11-20 | — | — | US | claimed |
| US-20030195367-A1 | Method for preparing a fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry | LABORATOIRES EXPANSCIENCE (FR) | 2003-10-16 | — | — | US | claimed |
| US-20030150008-A1 | Transgenic plants containing altered levels of steroid compounds | MONSANTO TECHNOLOGY, L.L.C. | 2003-08-07 | — | — | US | claimed |
| WO-2002061072-A2 | TRANSGENIC PLANTS CONTAINING ALTERED LEVELS OF STEROID COMPOUNDS | MONSANTO TECHNOLOGY LLC (US) | 2002-08-08 | — | — | WO | claimed |
| US-12577526-B2 | Massively parallel on-chip construction of synthetic microbial communities | THE BROAD INSTITUTE, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| US-4808574-A | LEUKOANTHOCYANES | NAUCHNO-ISSLEDOVATELSKY INSTITUT SADOVODSTVA (SU) | 1989-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030195367-A1 | Method for preparing a fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry | LSS, CYP51A1, CYP46A1 | PTPN1 2796/4885CRYAB 4823/4885MAPT 4447/4885 |
| US-20030150008-A1 | Transgenic plants containing altered levels of steroid compounds | HMGCR, CYP11A1, CYP46A1 | PTPN1 4142/4885CRYAB 694/4885MAPT 3405/4885 |
| US-20260020564-A1 | FUNGAL DISEASES REDUCTION AND YIELD IMPROVEMENT METHODS AND COMPOSITION THEREOF | FBP1, ERG28, CYP51A1 | PTPN1 1161/4885CRYAB 3749/4885MAPT 1369/4885 |
| US-20260020568-A1 | FUNGAL DISEASES REDUCTION AND YIELD IMPROVEMENT METHODS AND COMPOSITION THEREOF | GYS2, GYS1, FAR1 | PTPN1 1198/4885CRYAB 4152/4885MAPT 3328/4885 |
| US-12577526-B2 | Massively parallel on-chip construction of synthetic microbial communities | STUB1, SAMM50, CD14 | PTPN1 85/4885CRYAB 1546/4885MAPT 1771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.